Samsung Biologics Co.,Ltd. (KRX:207940)

Samsung Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	72,526,306	67,544,126	54,092,240	58,433,854	59,746,995	54,652,290
Market Cap Growth	22.02%	24.87%	-7.43%	-2.20%	9.32%	90.76%
Enterprise Value	72,660,573	67,525,830	54,470,492	57,778,382	59,669,232	54,358,190
Last Close Price	1019000.00	949000.00	760000.00	821000.00	893509.47	817318.74
PE Ratio	56.68	62.35	63.07	73.22	151.80	226.80
Forward PE	54.54	62.18	60.08	82.37	112.20	-
PS Ratio	14.81	14.85	14.64	19.47	38.10	46.92
PB Ratio	6.43	6.19	5.50	6.50	11.97	11.88
P/TBV Ratio	8.48	8.52	8.23	10.14	12.05	11.95
P/FCF Ratio	357.06	189.90	80.60	-	1235.91	875.48
P/OCF Ratio	35.34	40.71	32.46	61.31	131.43	270.44
PEG Ratio	2.78	3.19	3.45	3.32	3.45	-
EV/Sales Ratio	14.83	14.85	14.74	19.25	38.05	46.67
EV/EBITDA Ratio	32.68	35.19	33.97	44.72	85.35	124.54
EV/EBIT Ratio	45.30	51.15	48.91	58.74	111.05	185.66
EV/FCF Ratio	357.72	189.85	81.16	-	1234.30	870.77
Debt / Equity Ratio	0.13	0.14	0.19	0.28	0.26	0.17
Debt / EBITDA Ratio	0.64	0.77	1.19	1.95	1.85	1.80
Debt / FCF Ratio	6.99	4.18	2.85	-	26.74	12.57
Asset Turnover	0.29	0.27	0.23	0.24	0.22	0.19
Inventory Turnover	0.84	0.83	0.76	0.91	1.02	1.37
Quick Ratio	0.36	0.35	0.50	0.76	1.24	1.45
Current Ratio	1.45	1.43	1.33	1.54	2.55	2.97
Return on Equity (ROE)	12.02%	10.45%	9.12%	11.42%	8.21%	5.38%
Return on Assets (ROA)	5.84%	4.94%	4.27%	5.01%	4.67%	2.97%
Return on Capital (ROIC)	8.12%	6.84%	5.99%	6.91%	5.76%	3.52%
Return on Capital Employed (ROCE)	11.50%	9.80%	9.40%	7.90%	7.80%	5.00%
Earnings Yield	1.76%	1.60%	1.59%	1.37%	0.66%	0.44%
FCF Yield	0.28%	0.53%	1.24%	-0.01%	0.08%	0.11%
Buyback Yield / Dilution	-	-	-1.95%	-5.51%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.